Stephanie Keludjian
Key Account Manager @Hologic, Inc.
Los Angeles, CA, US
EMAILS
s••••••••@hologic.com
MOBILE NUMBERS
+18•••••••36
Signup · Get unlimited contacts
WORK HISTORY
Jan 2015 — Present
Key Account Manager @Hologic, Inc.
View department →
Breast Cancer Index Know when extended endocrine therapy is beneficial. Avoid it when it isn\'t. The National Comprehensive Cancer Network® (NCCN®) now recognizes Breast Cancer Index™ (BCI) as the only test that predicts benefit from extended endocrine therapy in early-stage, HR+ breast cancer.1 That means avoiding overtreatment for the patients for whom endocrine therapy beyond 5 years has no impact.2-7 And informing treatment for the patients it can help.
SKILLS
SurgeryCardiologyCancerUrologyCapital EquipmentGeneticsSellingMedical DevicesOncologyHealthcareMolecular DiagnosticsProduct LaunchSalesPharmaceutical SalesHospitalsSales OperationsBiotechnology
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.